Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neo-adjuvant Chemotherapy in Locally Advanced Gastric Cancer
NCT00414271Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Jan 2006
- Primary completion
- Oct 2015
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, capecitabine in gastric cancer (GC), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Jan 2006; status: completed.
02
Drugs
docetaxelcapecitabine
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00414271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00414271.